A new study presented at the International Association for the Study of Lung Cancer 2025 World Conference on Lung Cancer (WCLC) demonstrates that monitoring circulating tumor DNA (ctDNA) can refine ...
BOCA RATON, Fla., July 13, 2026--(BUSINESS WIRE)--Massive Bio, a technology company that uses artificial intelligence to help cancer patients identify clinical trials for which they may be eligible, ...
Cancer clinical trial matching company Massive Bio is partnering with patient advocacy organization Sequence Me Now to expand access to oncology clinical trials through linked resources on the ...
Massive Bio, a technology company that uses artificial intelligence to help cancer patients identify clinical trials for which they may be eligible, today announced a new partnership with Sequence Me ...
Sequence Me Now’s self-advocacy resources now connect patients to Massive Bio’s AI-powered clinical trial matching—linking genomic testing to treatment options ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results